BIOLOGICAL · Unmapped registry intervention
ProTmune
Find medicine records ·
Find other trials using this name
Clinical trial
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
NCT02743351
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
Control Arm
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hematologic Malignanciesunresolved
Interventions
ProTmuneBIOLOGICAL
Control ArmBIOLOGICAL
Sponsors & collaborators
Fate Therapeuticslead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1San AntonioTexas, United States1NashvilleTennessee, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1PortlandOregon, United States1IndianapolisIndiana, United States1DetroitMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02743351 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.